1. Home
  2. PNW vs EXAS Comparison

PNW vs EXAS Comparison

Compare PNW & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pinnacle West Capital Corporation

PNW

Pinnacle West Capital Corporation

HOLD

Current Price

$88.06

Market Cap

10.6B

Sector

Utilities

ML Signal

HOLD

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

HOLD

Current Price

$101.06

Market Cap

11.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PNW
EXAS
Founded
1985
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Medical Specialities
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6B
11.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PNW
EXAS
Price
$88.06
$101.06
Analyst Decision
Buy
Buy
Analyst Count
13
20
Target Price
$96.23
$76.38
AVG Volume (30 Days)
1.4M
10.3M
Earning Date
11-03-2025
11-03-2025
Dividend Yield
4.13%
N/A
EPS Growth
N/A
N/A
EPS
4.92
N/A
Revenue
$5,307,180,000.00
$3,082,033,000.00
Revenue This Year
$4.78
$19.40
Revenue Next Year
$4.15
$13.51
P/E Ratio
$17.93
N/A
Revenue Growth
5.70
14.47
52 Week Low
$81.47
$38.81
52 Week High
$96.50
$101.87

Technical Indicators

Market Signals
Indicator
PNW
EXAS
Relative Strength Index (RSI) 40.88 89.74
Support Level $88.24 $100.98
Resistance Level $90.97 $101.43
Average True Range (ATR) 1.15 2.25
MACD -0.09 0.53
Stochastic Oscillator 14.41 97.74

Price Performance

Historical Comparison
PNW
EXAS

About PNW Pinnacle West Capital Corporation

Pinnacle West is a holding company whose principal subsidiary is Arizona Public Service, a vertically integrated electric utility serving approximately 1.4 million customers across a 35,000-square-mile territory in central Arizona, including the Phoenix area. APS owns or leases 6.5 gigawatts of power generation capacity, including a 29% ownership stake in one of the largest nuclear plants in the US, Palo Verde. Half of the electricity that APS supplies to customers comes from clean energy sources, including nuclear.

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: